Turid Aas
Haukeland University Hospital · 130 works · 16,274 citations · h-index 30
Top works
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
- Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
- Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
- Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.
- Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
- Genital Ulcers as Initial Manifestation of Epstein-Barr Virus Infection: Two New Cases and a Review of the Literature
- Primary Systemic Treatment with Weekly Doxorubicin Monotherapy in Women with Locally Advanced Breast Cancer; Clinical Experience and Parameters Predicting Outcome
- Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
- Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels
- Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy
- Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics
- Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status
- DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
- Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer
- Impact of EMG Changes in Continuous Vagal Nerve Monitoring in High‐Risk Endocrine Neck Surgery
- Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel
- Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)